Notes - Segment Information

Astellas Pharma Inc. - Filing #7332273

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
Notes - Segment information
Segment information
Revenue
Revenue
1,603,672,000,000 JPY
1,518,619,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
-3,165,000,000 JPY
1,260,000,000 JPY
Profit (loss) before tax
24,969,000,000 JPY
132,361,000,000 JPY
Assets
3,569,603,000,000 JPY
2,456,518,000,000 JPY
Investments accounted for using equity method
15,684,000,000 JPY
12,689,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.